心臟血管和胸腔手術
抗凝血之處置和抗凝逆轉
Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. (開啟新視窗)
出處: Thromb Haemost 2016;116(5):879-90.
檢索: PubMed 27488143
DOI碼: 10.1160/TH16-04-0266
Pharmacological prophylaxis of bleeding in surgical patients treated with aspirin. (開啟新視窗)
出處: Eur J Anaesthesiol Suppl 1997;14:38-41.
檢索: PubMed 9088834
Reversal of warfarin: case-based practice recommendations. (開啟新視窗)
出處: Circulation 2012;125(23):2944-7.
檢索: PubMed 22689931
DOI碼: 10.1161/CIRCULATIONAHA.111.081489
Stopping antiplatelet medication before coronary artery bypass graft surgery: is there an optimal timing to minimize bleeding? (開啟新視窗)
出處: Eur J Cardiothorac Surg 2015;48(4):e64-70.
檢索: PubMed 26248820
DOI碼: 10.1093/ejcts/ezv269
Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit? (開啟新視窗)
出處: Interact Cardiovasc Thorac Surg 2012;14(4):406-14.
檢索: PubMed 22228288
DOI碼: 10.1093/icvts/ivr124
Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes. (開啟新視窗)
出處: Eur J Cardiothorac Surg 2007;31(6):1058-69.
檢索: PubMed 17306555
DOI碼: 10.1016/j.ejcts.2007.01.029
Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery. (開啟新視窗)
出處: J Cardiovasc Surg (Torino) 2008;49(2):277-84.
檢索: PubMed 18431350
Idarucizumab for dabigatran reversal. (開啟新視窗)
出處: N Engl J Med 2015;373(6):511-20.
檢索: PubMed 26095746
DOI碼: 10.1056/NEJMoa1502000
Idarucizumab for dabigatran reversal - full cohort analysis. (開啟新視窗)
出處: N Engl J Med 2017;377(5):431-41.
檢索: PubMed 28693366
DOI碼: 10.1056/NEJMoa1707278
Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. (開啟新視窗)
出處: J Cardiothorac Vasc Anesth 2007;21(6):851-4.
檢索: PubMed 18068065
DOI碼: 10.1053/j.jvca.2007.05.009
Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. (開啟新視窗)
出處: Circulation 2013;128(11):1234-43.
檢索: PubMed 23935011
DOI碼: 10.1161/CIRCULATIONAHA.113.002283
Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. (開啟新視窗)
出處: JAMA Surg 2013;148(6):538-47.
檢索: PubMed 23426385
DOI碼: 10.1001/jamasurg.2013.1560
Andexanet alfa for the reversal of Factor Xa inhibitor activity. (開啟新視窗)
出處: N Engl J Med 2015;373(25):2413-24.
檢索: PubMed 26559317
DOI碼: 10.1056/NEJMoa1510991
Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. (開啟新視窗)
出處: Blood 2012;119(9):2172-4.
檢索: PubMed 22383791
DOI碼: 10.1182/blood-2011-11-393587
Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting. (開啟新視窗)
出處: J Thorac Cardiovasc Surg 2011;141(5):1145-9.
檢索: PubMed 20709334
DOI碼: 10.1016/j.jtcvs.2010.07.003